Brain Advance Access published online on April 21, 2006
Brain, doi:10.1093/brain/awl075
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute for Multiple Sclerosis Research, University of Goettingen and Gemeinnützige Hertie Stiftung, Germany
* To whom correspondence should be addressed. In view of disease heterogeneity of multiple sclerosis and limited access to ex vivo specimens, different approaches must be undertaken to better understand disease pathogenesis and new therapeutic challenges. Here, we critically discuss models of experimental autoimmune encephalomyelitis (EAE) that reproduce specific features of the histopathology and neurobiology of multiple sclerosis and their shortcomings as tools to investigate emerging therapeutic approaches. By using EAE models we have understood mechanisms of T-cell mediated immune damage of the CNS, and the associated effector cascade of innate immunity. Also, the importance of humoral components of the immune system for demyelination has been delineated in EAE, before it was applied therapeutically to subtypes of multiple sclerosis. Yet, similar to multiple sclerosis, EAE is also heterogeneous and influenced by the selected autoantigen, species and the genetic background. In particular, the relevance of cytotoxic CD8 T cells for human multiple sclerosis has been underestimated in most EAE models, and no EAE model exists that mimics primary progressive disease courses of multiple sclerosis. Seventy years after the first description of EAE and the publication of >7000 articles, we are aware of the obvious limitations of EAE as a model of multiple sclerosis, but feel strongly that when used appropriately it will continue to provide a crucial tool for improving our understanding and treatment of this devastating disease.
Received February 8, 2006
Revised March 3, 2006
Accepted March 7, 2006
Review Article
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Ralf Gold 1 *,
Christopher Linington 2,
and
Hans Lassmann 3
2 Institute of Medical Sciences, University of Aberdeen, Scotland, UK
3 Center for Brain Research, Medical University of Vienna, Austria
Ralf Gold, E-mail: r.gold{at}med.uni-goettingen.de
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Mildner, M. Mack, H. Schmidt, W. Bruck, M. Djukic, M. D. Zabel, A. Hille, J. Priller, and M. Prinz CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system Brain, September 1, 2009; 132(9): 2487 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bittner, S. G. Meuth, K. Gobel, N. Melzer, A. M. Herrmann, O. J. Simon, A. Weishaupt, T. Budde, D. A. Bayliss, M. Bendszus, et al. TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system Brain, September 1, 2009; 132(9): 2501 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Dodson, J. S. Boomer, C. M. Deppong, D. D. Shah, J. Sim, T. L. Bricker, J. H. Russell, and J. M. Green Targeted Knock-In Mice Expressing Mutations of CD28 Reveal an Essential Pathway for Costimulation Mol. Cell. Biol., July 1, 2009; 29(13): 3710 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klemann, B. J.E. Raveney, A. K. Klemann, T. Ozawa, S. von Horsten, K. Shudo, S. Oki, and T. Yamamura Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Am. J. Pathol., June 1, 2009; 174(6): 2234 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Mannie, D. J. Abbott, and J. L. Blanchfield Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN-{beta} Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance J. Immunol., May 1, 2009; 182(9): 5331 - 5341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kalyvas, C. Baskakis, V. Magrioti, V. Constantinou-Kokotou, D. Stephens, R. Lopez-Vales, J.-Q. Lu, V. W. Yong, E. A. Dennis, G. Kokotos, et al. Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis Brain, May 1, 2009; 132(5): 1221 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wiendl and R. Hohlfeld Multiple sclerosis therapeutics: Unexpected outcomes clouding undisputed successes Neurology, March 17, 2009; 72(11): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Brambilla, T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea Transgenic Inhibition of Astroglial NF-{kappa}B Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation J. Immunol., March 1, 2009; 182(5): 2628 - 2640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Razmara, B. Hilliard, A. K. Ziarani, R. Murali, S. Yellayi, M. Ghazanfar, Y. H. Chen, and M. L. Tykocinski Fn14-TRAIL, a Chimeric Intercellular Signal Exchanger, Attenuates Experimental Autoimmune Encephalomyelitis Am. J. Pathol., February 1, 2009; 174(2): 460 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Buckley, P. Goldsmith, and R. J. M. Franklin Zebrafish myelination: a transparent model for remyelination? Dis. Model. Mech., November 1, 2008; 1(4-5): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bartels, K. Spate, H. Krampe, and H. Ehrenreich Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis Therapeutic Advances in Neurological Disorders, November 1, 2008; 1(3): 193 - 206. [Abstract] [PDF]
|
|
|
|
|
|
M. B. Sattler, S. K. Williams, C. Neusch, M. Otto, J. R. Pehlke, M. Bahr, and R. Diem Flupirtine as Neuroprotective Add-On Therapy in Autoimmune Optic Neuritis Am. J. Pathol., November 1, 2008; 173(5): 1496 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Piccio, J. L. Stark, and A. H. Cross Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis J. Leukoc. Biol., October 1, 2008; 84(4): 940 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases Brain, July 1, 2008; 131(7): 1686 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Anderson, D. W. Hampton, R. Patani, G. Pryce, R. A. Crowther, R. Reynolds, R. J. M. Franklin, G. Giovannoni, D. A. S. Compston, D. Baker, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis Brain, July 1, 2008; 131(7): 1736 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Doi, S. Oki, T. Ozawa, H. Hohjoh, S. Miyake, and T. Yamamura Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines PNAS, June 17, 2008; 105(24): 8381 - 8386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wust, J. van den Brandt, D. Tischner, A. Kleiman, J. P. Tuckermann, R. Gold, F. Luhder, and H. M. Reichardt Peripheral T Cells Are the Therapeutic Targets of Glucocorticoids in Experimental Autoimmune Encephalomyelitis J. Immunol., June 15, 2008; 180(12): 8434 - 8443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Johnson, S. Tsutsui, and F. R. Jirik Antigen-Induced Pten Gene Deletion in T Cells Exacerbates Neuropathology in Experimental Autoimmune Encephalomyelitis Am. J. Pathol., April 1, 2008; 172(4): 980 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cabrelle, I. Dell'Aica, L. Melchiori, S. Carraro, E. Brunetta, R. Niero, E. Scquizzato, G. D'Intino, L. Calza, S. Garbisa, et al. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease J. Leukoc. Biol., January 1, 2008; 83(1): 212 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gold and F. Luhder Interleukin-17--Extended Features of a Key Player in Multiple Sclerosis Am. J. Pathol., January 1, 2008; 172(1): 8 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Frisoni, L. McPhie, S.-A. Kang, M. Monestier, M. Madaio, M. Satoh, and R. Caricchio Lack of Chromatin and Nuclear Fragmentation In Vivo Impairs the Production of Lupus Anti-Nuclear Antibodies J. Immunol., December 1, 2007; 179(11): 7959 - 7966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Junker, J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair Multiple sclerosis: T-cell receptor expression in distinct brain regions Brain, November 1, 2007; 130(11): 2789 - 2799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rasmussen, Y. Wang, P. Kivisakk, R. T. Bronson, M. Meyer, J. Imitola, and S. J. Khoury Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis Brain, November 1, 2007; 130(11): 2816 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Mars, J. Bauer, D. A. Gross, F. Bucciarelli, H. Firat, D. Hudrisier, F. Lemonnier, K. Kosmatopoulos, and R. S. Liblau CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice J. Immunol., October 15, 2007; 179(8): 5090 - 5098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis J. Immunol., October 15, 2007; 179(8): 5228 - 5237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ehrenreich, B. Fischer, C. Norra, F. Schellenberger, N. Stender, M. Stiefel, A.-L. Siren, W. Paulus, K.-A. Nave, R. Gold, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis Brain, October 1, 2007; 130(10): 2577 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Friedman-Levi, H. Ovadia, R. Hoftberger, O. Einstein, O. Abramsky, H. Budka, and R. Gabizon Fatal Neurological Disease in Scrapie-Infected Mice Induced for Experimental Autoimmune Encephalomyelitis J. Virol., September 15, 2007; 81(18): 9942 - 9949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, S. L. Carter, M. J. Hofer, P. Manders, D. R. Getts, M. T. Getts, A. Dreykluft, B. Lu, C. Gerard, N. J. C. King, et al. CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System J. Immunol., September 1, 2007; 179(5): 2774 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nessler, S. Boretius, C. Stadelmann, A. Bittner, D. Merkler, H.-P. Hartung, T. Michaelis, W. Bruck, J. Frahm, N. Sommer, et al. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage Brain, August 1, 2007; 130(8): 2186 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Herrero-Herranz, L. A. Pardo, G. Bunt, R. Gold, W. Stuhmer, and R. A. Linker Re-Expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 Is Implicated in Oligodendroglial Proliferation Am. J. Pathol., August 1, 2007; 171(2): 589 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Forte, B. G. Gold, G. Marracci, P. Chaudhary, E. Basso, D. Johnsen, X. Yu, J. Fowlkes, M. Rahder, K. Stem, et al. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis PNAS, May 1, 2007; 104(18): 7558 - 7563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. v. d. Brandt, F. Luhder, K. G. McPherson, K. L. de Graaf, D. Tischner, S. Wiehr, T. Herrmann, R. Weissert, R. Gold, and H. M. Reichardt Enhanced Glucocorticoid Receptor Signaling in T Cells Impacts Thymocyte Apoptosis and Adaptive Immune Responses Am. J. Pathol., March 1, 2007; 170(3): 1041 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tischner, A. Weishaupt, J. v. d. Brandt, N. Muller, N. Beyersdorf, C. W. Ip, K. V. Toyka, T. Hunig, R. Gold, T. Kerkau, et al. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis Brain, October 1, 2006; 129(10): 2635 - 2647. [Abstract] [Full Text] [PDF]
|
|